SCHEMBL9223409

SCHEMBL9223409

CSc1nnc(-c2ccccc2F)n1C

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.63
ALDH1A1 P00352 7/20 0.57
KDM4E B2RXH2 4/20 0.57
GAA P10253 2/20 0.57
GLA P06280 1/20 0.57
HSD17B10 Q99714 1/20 0.57
HSD11B1 P28845 3/20 0.52
MEN1 O00255 1/20 0.49
TSHR P16473 1/20 0.49
PKM P14618 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9223422 0.83 NPC1 (0.55) KMT2AALDH1A1GAAHSD11B1PKM
SCHEMBL6244967 0.80 KMT2A (0.63) KMT2AALDH1A1KDM4EGAAGLA
SCHEMBL9226272 0.80 HSD11B1 (0.71) KMT2AALDH1A1KDM4EGAAGLA
SCHEMBL9226657 0.80 SMN1; SMN2 (0.59) KMT2AALDH1A1GAAMEN1TSHR
SCHEMBL14077015 0.79 HSD11B1 (0.58) HSD11B1
SCHEMBL6247799 0.78 KMT2A (1.00) KMT2AALDH1A1KDM4EGAAGLA
SCHEMBL4205993 0.77 RAB9A (0.62) KMT2AALDH1A1GAAMEN1PKM
SCHEMBL4200868 0.77 RAB9A (0.66) KMT2AALDH1A1MEN1HTTSMN1; SMN2
SCHEMBL1544072 0.76 HSD11B1 (0.55) GAAHSD11B1
SCHEMBL974759 0.75 ALDH1A1 (0.69) KMT2AALDH1A1KDM4EGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0495226-B1 3-Aryl-5-alkylthio-4H-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma MERRELL DOW PHARMA (US) 1995-10-11 EP disclosed
US-5260450-A Anticonvulsants MERRELL DOW PHARMACEUTICALS INC. (US) 1993-11-09 US disclosed
EP-0276793-B1 3-ARYL-5-ALKYLTHIO-4H-1,2,4-TRIAZOLES MERRELL DOW PHARMACEUTICALS INC. (US) 1993-06-16 EP disclosed
US-5158968-A 3-aryl-5-alkylthio-4H-1,2,4-traizoles for treatment of hyperreflexia due to spinal trauma MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-27 US disclosed
US-5143933-A Anticonvulsants MERRELL DOW PHARMACEUTICALS INC. (US) 1992-09-01 US disclosed
EP-0495226-A2 3-Aryl-5-alkylthio-4H-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-22 EP disclosed
US-4981863-A ANTIANXIETY MERRELL DOW PHARMACEUTICALS (US) 1991-01-01 US disclosed
US-4900743-A TREATING MUSCLE SPASMS MERRELL DOW PHARMACEUTICALS INC. (US) 1990-02-13 US disclosed
EP-0276793-A2 3-Aryl-5-alkylthio-4H-1,2,4-triazoles MERRELL DOW PHARMACEUTICALS INC. (US) 1988-08-03 EP disclosed